Tenet Healthcare Corporation
THC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.57 | -0.52 | 0.27 | -0.29 |
| FCF Yield | 4.36% | 4.63% | 5.06% | -5.51% |
| EV / EBITDA | 31.57 | 25.18 | 19.44 | 21.08 |
| Quality | ||||
| ROIC | 2.90% | 2.73% | 3.08% | 2.90% |
| Gross Margin | 58.33% | 82.32% | 42.03% | 40.34% |
| Cash Conversion Ratio | 1.83 | 1.79 | 1.31 | -0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.14% | 1.31% | 1.80% | 2.53% |
| Free Cash Flow Growth | 4.71% | 15.73% | 197.13% | -178.78% |
| Safety | ||||
| Net Debt / EBITDA | 11.49 | 9.99 | 8.66 | 9.66 |
| Interest Coverage | 4.32 | 4.00 | 4.62 | 4.04 |
| Efficiency | ||||
| Inventory Turnover | 6.37 | 2.76 | 8.80 | 8.75 |
| Cash Conversion Cycle | 23.04 | -35.50 | 25.10 | 26.00 |